Discovery Process Chemistry (DPC) bridges the gap between early discovery and scalable development. This case study reveals how early integration of process thinking can transform drug development. In just 18 months—over 25% faster than typical timelines—a CNS project advanced from hit confirmation to IND filing. By breaking down the traditional silos between discovery chemistry, process chemistry, and R&D, the team achieved a scalable, robust route and delivered high‑quality material ahead of schedule.

Highlights

• Accelerated Timeline: From hit to IND in 18 months, enabling faster progression to clinic.
• Seamless Collaboration: Discovery, DPC, and Process R&D teams worked in parallel to avoid late stage surprises.
• Scalable & Robust Process: Early process awareness eliminated bottlenecks and delivered reliable synthesis route.
• IND Readiness: All CMC, pharmacology, and toxicology data completed on time for a successful submission.

Download the full case study to see how early process integration can accelerate your next program.